Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prime Medicine (PRME) Revenue (2024 - 2025)

Prime Medicine (PRME) has disclosed Revenue for 2 consecutive years, with $838000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 61.61% year-over-year to $838000.0, compared with a TTM value of $4.6 million through Dec 2025, up 55.28%, and an annual FY2025 reading of $4.6 million, up 55.28% over the prior year.
  • Revenue was $838000.0 for Q4 2025 at Prime Medicine, down from $1.2 million in the prior quarter.
  • Across five years, Revenue topped out at $2.2 million in Q4 2024 and bottomed at $209000.0 in Q3 2024.